Steven Zelenkofske

Steven L.
Zelenkofske currently serves as Director & Chief Strategy Officer at DiNAQOR AG since 2023.
He is also an Associate Professor at Philadelphia College of Osteopathic Medicine and Hershey Medical Center.
Former positions include Independent Director at Cadrenal Therapeutics, Inc. from 2023 to 2026, Chief Medical Officer at SwanBio Therapeutics, Inc. from 2020 to 2022, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2018 to 2020, Chief Medical Officer at uniQure NV from 2017 to 2018, Chief Medical Officer at Regado Biosciences, Inc. from 2009 to 2014, VP-Cardiovascular & Thrombosis Medical Unit at Sanofi-Aventis Pharmaceuticals from 2007 to 2009, Chief Patient Safety Officer at Cardiac Rhythm Management from 2006 to 2007, Senior Director at Novartis Pharmaceuticals Corp.
from 2002 to 2006, and Clinical Director at The Heart Care Group.
Education includes undergraduate and graduate degrees from Emory University and a doctorate from Philadelphia College of Osteopathic Medicine.